 "Merck to help make Johnson & Johnson's Covid-19 vaccine, says report")
Merck & Co Inc will help make rival Johnson & Johnson's single-shot Covid-19 vaccine, the Washington Post reported on Tuesday, citing senior officials from the Biden administration.
President Joe Biden is expected to make the announcement on Tuesday, the report said.
US-based Merck halted the development of two of its own coronavirus vaccines in January to instead focus on its two Covid-19 treatments.
The company said last month that it was in talks with governments and companies to potentially help with manufacturing of Covid-19 vaccines that have been authorized.
The drugmaker will dedicate two US facilities to Johnson & Johnson's vaccine, according to the report.
"Merck remains steadfast in our commitment to contribute to the global response to the pandemic," the company said.
"Merck remains steadfast in our commitment to contribute to the global response to the pandemic," the company said.
J&J did not immediately respond to a Reuters request for comment.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%